Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

[Efficacy of Disease Management Programs Asthma and COPD? Results of a Cross-Sectional Study].

Kanniess F, Krockenberger K, Oepen P, Hedrich R, Olbrich D, Hessler N, Ziegler A, Langer-Brauburger B.

Dtsch Med Wochenschr. 2019 Jan;144(2):e1. doi: 10.1055/a-0837-2602. Epub 2019 Jan 23. German. No abstract available.

PMID:
30674053
2.

[Efficacy of Disease Management Programs Asthma and COPD? Results of a Cross-Sectional Study].

Kanniess F, Krockenberger K, Oepen P, Hedrich R, Olbrich D, Hessler N, Ziegler A, Langer-Brauburger B.

Dtsch Med Wochenschr. 2019 Jan;144(2):e12-e20. doi: 10.1055/a-0672-2461. Epub 2018 Nov 14. German. Erratum in: Dtsch Med Wochenschr. 2019 Jan;144(2):e1.

PMID:
30428493
3.

Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.

Schmidt O, Petro W, Hoheisel G, Kanniess F, Oepen P, Langer-Brauburger B.

Respir Med. 2017 Oct;131:166-174. doi: 10.1016/j.rmed.2017.08.017. Epub 2017 Aug 19.

PMID:
28947024
4.

Prolonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study.

Hesselbarth S, Hermanns K, Oepen P.

Expert Opin Pharmacother. 2015 Mar;16(4):457-64. doi: 10.1517/14656566.2015.1001737. Epub 2015 Jan 22.

PMID:
25612469
5.
6.

Plasmids containing cos ends inhibit the replication of phage phi CTX in Pseudomonas aeruginosa.

Xiong G, Oepen P, Geiben R, el-Idrissi AH, Lutz F.

Virus Res. 1996 Mar;41(1):77-87.

PMID:
8725104

Supplemental Content

Support Center